BlackRock’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1B | Sell |
|
|||||
|
2025
Q2 | $920M | Sell |
|
|||||
|
2025
Q1 | $1.68B | Sell |
|
|||||
|
2024
Q4 | $790M | Sell |
|
|||||
|
2024
Q3 | $743M | Sell |
|
|||||
|
2024
Q2 | $537M | Sell |
|
|||||
|
2024
Q1 | $424M | Buy |
|
|||||
|
2023
Q4 | $533M | Buy |
|
|||||
|
2023
Q3 | $414M | Sell |
|
|||||
|
2023
Q2 | $340M | Sell |
|
|||||
|
2023
Q1 | $349M | Sell |
|
|||||
|
2022
Q4 | $332M | Buy |
|
|||||
|
2022
Q3 | $415M | Buy |
|
|||||
|
2022
Q2 | $368M | Buy |
|
|||||
|
2022
Q1 | $347M | Buy |
|
|||||
|
2021
Q4 | $298M | Sell |
|
|||||
|
2021
Q3 | $307M | Sell |
|
|||||
|
2021
Q2 | $344M | Sell |
|
|||||
|
2021
Q1 | $385M | Buy |
|
|||||
|
2020
Q4 | $407M | Buy |
|
|||||
|
2020
Q3 | $262M | Sell |
|
|||||
|
2020
Q2 | $267M | Buy |
|
|||||
|
2020
Q1 | $181M | Sell |
|
|||||
|
2019
Q4 | $193M | Buy |
|
|||||
|
2019
Q3 | $220M | Sell |
|
|||||
|
2019
Q2 | $175M | Sell |
|
|||||
|
2019
Q1 | $186M | Buy |
|
|||||
|
2018
Q4 | $207M | Sell |
|
|||||
|
2018
Q3 | $221M | Buy |
|
|||||
|
2018
Q2 | $223M | Buy |
|
|||||
|
2018
Q1 | $212M | Buy |
|
|||||
|
2017
Q4 | $206M | Buy |
|
|||||
|
2017
Q3 | $150M | Buy |
|
|||||
|
2017
Q2 | $88.4M | Buy |
|
|||||
|
2017
Q1 | $75.6M | Buy |
|
|||||
|
2016
Q4 | $188K | Sell |
|
|||||
|
2016
Q3 | $178K | Sell |
|
|||||
|
2016
Q2 | $151K | Buy |
|
|||||
|
2016
Q1 | $16K | Buy |
|
|||||
|
2015
Q4 | $6K | Hold |
|
|||||
|
2015
Q3 | $5K | Hold |
|
|||||
|
2015
Q2 | $7K | Sell |
|
|||||
|
2015
Q1 | $10K | Hold |
|
|||||
|
2014
Q4 | $5K | Hold |
|
|||||
|
2014
Q3 | $5K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $7K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $1K | Hold |
|
|||||
|
2013
Q2 | $1K | Buy |
|